These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 2604197)
21. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Damas P; Reuter A; Gysen P; Demonty J; Lamy M; Franchimont P Crit Care Med; 1989 Oct; 17(10):975-8. PubMed ID: 2791581 [TBL] [Abstract][Full Text] [Related]
22. Effects of removing circulatory tumor necrosis factor by immunoadsorption on experimental endotoxin shock animals. Zhang X; Hou F; Liang M; Long H; Wang G; Tang B; Zhang G; Zhu Y; Zhuo H Chin Med J (Engl); 1997 Nov; 110(11):843-6. PubMed ID: 9772415 [TBL] [Abstract][Full Text] [Related]
23. [Effect of antibiotic therapy on levels of proinflammatory cytokines: interleukin IL-1, IL-6 and tumor necrosis factor TNF-alpha in serum of patients with Lyme borreliosis]. Kondrusik M; Swierzbińska R; Zajkowska JM; Pancewicz SA; Grygorczuk S; Hermanowska-Szpakowicz T Wiad Lek; 2002; 55(5-6):276-81. PubMed ID: 12235693 [TBL] [Abstract][Full Text] [Related]
24. Macrophage migration inhibitory factor (MIF) in meningococcal septic shock and experimental human endotoxemia. Sprong T; Pickkers P; Geurts-Moespot A; van der Ven-Jongekrijg J; Neeleman C; Knaup M; Leroy D; Calandra T; van der Meer JW; Sweep F; van Deuren M Shock; 2007 May; 27(5):482-7. PubMed ID: 17438452 [TBL] [Abstract][Full Text] [Related]
25. Cytokines (IL-6, TNF-alpha, IL-1alpha) and soluble interleukin-2 receptor as serum tumor markers in multiple myeloma. Filella X; Blade J; Guillermo AL; Molina R; Rozman C; Ballesta AM Cancer Detect Prev; 1996; 20(1):52-6. PubMed ID: 8907203 [TBL] [Abstract][Full Text] [Related]
28. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Damas P; Ledoux D; Nys M; Vrindts Y; De Groote D; Franchimont P; Lamy M Ann Surg; 1992 Apr; 215(4):356-62. PubMed ID: 1558416 [TBL] [Abstract][Full Text] [Related]
29. Current advances in sepsis and septic shock with particular emphasis on the role of insulin. Das UN Med Sci Monit; 2003 Aug; 9(8):RA181-92. PubMed ID: 12942044 [TBL] [Abstract][Full Text] [Related]
30. [Plasma concentration of tumor necrosis factor correlated with gravity of septic shock]. Romieu M; Bousseau A; Riche F; Payen D Ann Fr Anesth Reanim; 1989; 8 Suppl():R238. PubMed ID: 2604196 [No Abstract] [Full Text] [Related]
31. Tumor necrosis factor and interleukin 1 appearance in experimental gram-negative septic shock. The effects of plasma exchange with albumin and plasma infusion. Busund R; Lindsetmo RO; Rasmussen LT; Røkke O; Rekvig OP; Revhaug A Arch Surg; 1991 May; 126(5):591-7. PubMed ID: 2021343 [TBL] [Abstract][Full Text] [Related]
33. The role of cytokines in septic shock and speculations on future therapies. Dofferhoff AS Neth J Med; 1991 Aug; 39(1-2):1-5. PubMed ID: 1961344 [No Abstract] [Full Text] [Related]
34. Hypoglycemia, hormones and cytokines in fatal meningococcal septicemia. Romijn JA; Godfried MH; Wortel C; Sauerwein HP J Endocrinol Invest; 1990 Oct; 13(9):743-7. PubMed ID: 2292658 [TBL] [Abstract][Full Text] [Related]
37. Low levels of cytokines and endotoxin in a fatal case of myocardial depression and septic shock due to Yersinia pseudotuberculosis. Valtonen M; Lommi J; Pohjola-Sintonen S; Ljungberg P; Hynninen M; Vaara M Scand J Infect Dis; 1995; 27(5):533-5. PubMed ID: 8588151 [No Abstract] [Full Text] [Related]
38. Significance of in vivo detection of tumor necrosis factor. Remick DG Lab Invest; 1991 Sep; 65(3):259-61. PubMed ID: 1890805 [No Abstract] [Full Text] [Related]